|
In Europe, over 20 million people are estimated to have had a
diagnosis of cancer, and the number of cancer survivors is further
increasing. To address needs of cancer survivors, several European
countries have established a cancer survivors' Right to be
Forgotten (RTBF), i.e. the right for cancer survivors to withhold,
under certain conditions, a previous cancer diagnosis to an insurer
when applying for an insurance policy (e.g. for life insurance as
mortgage protection). Furthermore, a European framework is under
development. The different jurisdictions, the complexity of RTBF
frameworks as well as lack of uniformity pose significant
challenges for European L&H insurers. Aspects important are the
details and implications of national and European legislations as
well as existing industry codes and the differential impact of the
various RTBF parameters.
This web session aims to give an overview and a deeper
understanding of the cancer survivors' Right to be Forgotten (RTBF)
and its current development inside and outside Europe. We will
discuss the different parameters of RTBF, such as product scope,
disease scope, minimum remission period (timeline) and others. We
will also provide solutions how to estimate the actuarial impact
depending on these RTBF parameters. Finally, its purpose is to help
understanding and navigating the most recent developments and
implications of RTBF for L&H insurance.
Your early-bird registration fee is € 120.00 (net) / € 142.80
(incl. VAT, if applicable) for bookings by 11 September 2024. After
this date, the fee will be € 170.00 (net) / € 202.30 (incl. VAT, if
applicable).
|
|